Dr. David Centurión
Dr. David Centurión
Professor of Cardiovascular Pharmacology in Center for Research and Advanced Studies (Cinvestav)
Verified email at - Homepage
Cited by
Cited by
Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications
CM Villalón, D Centurión
Naunyn-Schmiedeberg's archives of pharmacology 376, 45-63, 2007
Cardiovascular alterations after spinal cord injury: an overview
G Bravo, G Guízar-Sahagún, A Ibarra, D Centurión, CM Villalón
Current Medicinal Chemistry-Cardiovascular & Hematological Agents 2 (2), 133-148, 2004
An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy
CM Villalón, D Centurión, LF Valdivia, P De Vries, PR Saxena
Experimental migraine models and their relevance in migraine therapy
U Arulmani, S Gupta, AM VanDenBrink, D Centurión, CM Villalón, ...
Cephalalgia 26 (6), 642-659, 2006
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5‐HT1B/1D receptors and α2‐adrenoceptors
CM Villalón, P De Vries, G Rabelo, D Centurión, A Sánchez‐López, ...
British journal of pharmacology 126 (3), 585-594, 1999
Mediation of 5‐HT‐induced external carotid vasodilatation in GR 127935‐pretreated vagosympathectomized dogs by the putative 5‐HT7 receptor
CM Villalón, D Centurión, M Luján‐Estrada, JA Terrón, A Sánchez‐López
British journal of pharmacology 120 (7), 1319-1327, 1997
The suprachiasmatic nucleus is part of a neural feedback circuit adapting blood pressure response
FN Buijs, F Cazarez, MC Basualdo, F Scheer, M Perusquía, D Centurion, ...
Neuroscience 266, 197-207, 2014
Current and prospective pharmacological targets in relation to antimigraine action
S Mehrotra, S Gupta, KY Chan, CM Villalón, D Centurión, PR Saxena, ...
Naunyn-Schmiedeberg's archives of pharmacology 378, 371-394, 2008
5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats
D Centurión, E Glusa, A Sánchez-López, LF Valdivia, PR Saxena, ...
European journal of pharmacology 502 (3), 239-242, 2004
The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists
P De Vries, A Sánchez-López, D Centurión, JPC Heiligers, PR Saxena, ...
European journal of pharmacology 362 (1), 69-72, 1998
Characterization of putative 5‐HT7 receptors mediating tachycardia in the cat
CM Villalón, JPC Heiligers, D Centurión, P De Vries, PR Saxena
British journal of pharmacology 121 (6), 1187-1195, 1997
The 5‐HT1‐like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5‐HT1A, 5‐HT1B and 5‐HT1D subtypes
CM Villalón, D Centurión, G Rabelo, P de Vries, PR Saxena, ...
British journal of pharmacology 124 (5), 1001-1011, 1998
Characterization of the postjunctional α2C‐adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins
T Görnemann, H Von Wenckstern, B Kleuser, CM Villalón, D Centurión, ...
British journal of pharmacology 151 (2), 186-194, 2007
Pharmacological profile of the 5‐HT‐induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: Correlation with 5‐HT1 and putative 5‐ht5A/5B receptors
A Sánchez‐López, D Centurión, E Vázquez, U Arulmani, PR Saxena, ...
British journal of pharmacology 140 (4), 725-735, 2003
Operational characteristics of the 5-HT 1-like receptors mediating external carotid vasoconstriction in vagosympathectomized dogs: close resemblance to the 5-HT 1D receptor subtype
CM Villalón, A Sánchez-López, D Centurión
Naunyn-Schmiedeberg's archives of pharmacology 354, 550-556, 1996
Further characterization of the 5-HT 1 receptors mediating cardiac sympatho-inhibition in pithed rats: pharmacological correlation with the 5-HT 1B and 5-HT 1D subtypes
A Sánchez-López, D Centurión, E Vázquez, U Arulmani, PR Saxena, ...
Naunyn-Schmiedeberg's archives of pharmacology 369, 220-227, 2004
The 5-HT1 receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT1F, but not 5-HT1A or 5-HT1D, subtypes
A González-Hernández, G Manrique-Maldonado, J Lozano-Cuenca, ...
European journal of pharmacology 659 (2-3), 233-243, 2011
Potential vascular α1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat
D Centurión, S Mehotra, A Sánchez-López, S Gupta, ...
European journal of pharmacology 535 (1-3), 234-242, 2006
Donitriptan, but not sumatriptan, inhibits capsaicin‐induced canine external carotid vasodilatation via 5‐HT1B rather than 5‐HT1D receptors
E Muñoz‐Islas, S Gupta, LR Jiménez‐Mena, J Lozano‐Cuenca, ...
British journal of pharmacology 149 (1), 82-91, 2006
5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats
CM Villalón, D Centurión, M del Mar Fernández, A Morán, ...
Life sciences 64 (20), 1839-1847, 1999
The system can't perform the operation now. Try again later.
Articles 1–20